The present invention is directed to a benzoxazole compound represented by the following formula (1): ##STR1## (wherein R.sup.1 represents an alkyl group, a C.sub.6-10 aryl-C.sub.1-8 alkyl group, etc.; each of R.sup.2 and R.sup.3, which are identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; and n represents a number of 1 to 3) or a salt thereof and to a pharmaceutical compound containing the same. These compounds electively activate PPAR.alpha..

La actual invención se dirige a un compuesto del benzoxazole representado por el fórmula siguiente (1): ## del ## STR1 (en donde R.sup.1 representa un grupo alkyl, un grupo alkyl de C.sub.6-10 aryl-C.sub.1-8, el etc.; cada uno de R.sup.2 y de R.sup.3, a los cuales sea idéntico o diferente de uno a, representa a un átomo del hidrógeno, a un grupo metílico, o a grupo ethyl; y n representa un número de 1 a 3) o una sal de eso y a un compuesto farmacéutico que contiene igual. Estos compuestos electivo activan PPAR.alpha..

 
Web www.patentalert.com

< Naphthylsulfonic acids and related compounds as glucose uptake agonists

< Combination therapeutic compositions and method of use

> Cytoprotective benzofuran derivatives

> Tetrahydropyrimidone inhibitors of fatty acid binding protein and method

~ 00092